Antimicrobial Activity of D-Form Synthetic Peptides Against Metronidazole-Resistant and Susceptible Trichomonas

Özben Özden1, Tuba Polat1, Tanıl Kocagöz1,2

  • 1Graduate School of Health Sciences, Department of Medical Biotechnology, Acibadem University, Istanbul 34752, Türkiye.

Insights

New antimicrobial peptides show promise against metronidazole-resistant Trichomonas vaginalis, the cause of trichomoniasis. D-TN1 peptide effectively killed both susceptible and resistant strains in vitro, suggesting a potential new treatment for this common STI.

Area of Science:

  • Antimicrobial Peptides
  • Parasitic Infections
  • Drug Resistance

Background:

  • Trichomoniasis, caused by *Trichomonas vaginalis*, is the most common non-viral sexually transmitted infection globally.
  • Metronidazole (MTZ) is the primary treatment, but MTZ resistance in *T. vaginalis* is a growing concern.
  • Novel therapeutic strategies are needed to combat resistant strains of *T. vaginalis*.

Purpose of the Study:

  • To evaluate the in vitro antimicrobial activity of D-form synthetic peptides against *T. vaginalis*.
  • To investigate transcriptional changes associated with MTZ resistance and peptide treatment in *T. vaginalis*.
  • To identify potential new therapeutic alternatives for trichomoniasis.

Main Methods:

  • Minimum Lethal Concentration (MLC) assays were performed using D-form synthetic peptides (D-TN1, D-TN3, D-TN6) against MTZ-susceptible and MTZ-resistant *T. vaginalis* strains.
  • Comparative transcriptomic analysis was conducted on MTZ-resistant and susceptible isolates.
  • Differential gene expression analysis was performed on MTZ-resistant isolates before and after D-TN1 treatment.

Main Results:

  • D-TN1 demonstrated potent in vitro activity with an MLC of 16 µg/mL against both MTZ-susceptible and MTZ-resistant *T. vaginalis* strains.
  • Differential gene expression analysis revealed significant transcriptional differences between resistant and susceptible isolates (3395 genes).
  • D-TN1 treatment in resistant isolates led to the downregulation of ribosomal and metabolic pathways (3060 genes).

Conclusions:

  • D-form synthetic antimicrobial peptides, particularly D-TN1, exhibit significant in vitro efficacy against *T. vaginalis*, including MTZ-resistant strains.
  • Transcriptomic analysis provides insights into the molecular mechanisms underlying MTZ resistance and peptide action.
  • D-TN1 represents a promising candidate for a novel therapeutic agent against trichomoniasis, warranting further in vivo investigation.

Related Concept Videos

Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Antibiotic Selection00:57

Antibiotic Selection

Overview
Antimicrobial Proteins01:23

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...